[Seroprevalence of rickettsial infections of the Boutonneuse fever group or its apparent group in Bangui (Central African Republic)] NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Seroprevalence of rickettsial infections of the Boutonneuse fever group or its apparent group in Bangui (Central African Republic)]

Bull Soc Pathol Exot. 1995;88(3):126-8. Unique Identifier : AIDSLINE MED/96150688
Ekala MT; Gresenguet G; Belec L; Laboratoire de Virologie, Hopital Broussais, Paris, France.

Abstract: 115 sera from African individuals, including 66 HIV-1-infected individuals and 49 HIV-seronegative age-matched healthy controls, living in Bangui, Central African Republic, were screened for Rickettsia conorii antibody by indirect immunofluorescent assay; 53 (46%) sera had significant IgG to R. conorii titer, and 5 (4.3%) had significant IgM to R. conorii titer, without significant difference between HIV-positive and negative individuals. These findings indicate a great exposure to spotted fever group rickettsial infections in Bangui.
Keywords: Adult Antibodies, Bacterial/BLOOD Boutonneuse Fever/*EPIDEMIOLOGY/IMMUNOLOGY Case-Control Studies Central African Republic/EPIDEMIOLOGY English Abstract Female Fluorescent Antibody Technique, Indirect Human HIV Infections/EPIDEMIOLOGY HIV Seronegativity IgG/BLOOD IgM/BLOOD Male Prevalence Prospective Studies Rickettsia Infections/EPIDEMIOLOGY/IMMUNOLOGY Seroepidemiologic Methods JOURNAL ARTICLEKWDadultantibodies,bacterial/bloodboutonneusefever/
960530
M9651051

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .